XML 93 R81.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation Expense (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 14, 2019
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
shares
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Share-Based Compensation Expense (Details) [Line Items]              
Options issued (in Shares) | shares       627,160   2,738,912 4,923,549
Weighted-average grant date fair value (in Dollars per share) | $ / shares           $ 0.9 $ 0.63
Share-based compensation expense | $   $ 754 $ 225 $ 1,196 $ 277 $ 978,000 $ 208,000
Unrecognized compensation cost | $       $ 6,827   $ 4,857,000  
Weighted-average period       3 years 6 months   3 years 10 months 24 days  
Aggregate intrinsic value | $   $ 1,555 $ 0 $ 1,555 0 $ 3,336,000 1,676,000
Cash received from options exercised | $       $ 23,000 1,000 $ 114,000 $ 10,000
Common stock of shares (in Shares) | shares           1,715,918  
Number of employees           4  
Restricted Stock (in Shares) | shares       377,373      
Cash received from options exercised | $       $ 23 $ 0    
Restricted Shares [Member]              
Share-Based Compensation Expense (Details) [Line Items]              
Restricted Stock (in Shares) | shares           25,309  
Minimum [Member]              
Share-Based Compensation Expense (Details) [Line Items]              
Vesting period       1 year   1 year  
Restricted stock units directors term       1 year      
Maximum [Member]              
Share-Based Compensation Expense (Details) [Line Items]              
Vesting period       4 years   4 years  
Restricted stock units directors term       4 years      
Two Directors [Member]              
Share-Based Compensation Expense (Details) [Line Items]              
Common stock of shares (in Shares) | shares 223,166